THU0002 Etanercept and adalimumab exhibit heterogeneous early signatures of response in rheumatoid arthritis therapy

J Oliver; D Plant; G Orozco; K Hyrich; A Morgan; J Isaacs; AG Wilson; A Barton

doi:10.1136/annrheumdis-2017-eular.1739

Article info

PDF

Poster Presentations

Genomics, genetic basis of disease and HLA/T cell recognition

THU0002 Etanercept and adalimumab exhibit heterogeneous early signatures of response in rheumatoid arthritis therapy

Free

Authors

J Oliver 1Arthritis Research UK, Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, The University of Manchester PubMed articles Google scholar articles
D Plant 2NIHR Manchester Musculoskeletal BRU, Central Manchester Foundation Trust PubMed articles Google scholar articles
G Orozco 1Arthritis Research UK, Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, The University of Manchester PubMed articles Google scholar articles
K Hyrich 3Arthritis Research UK, Centre for Epidemiology, Centre for Musculoskeletal Research, Manchester Academic Health Sciences Centre, The University of Manchester, Manchester PubMed articles Google scholar articles
A Morgan 4Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Teaching Hospitals NHS Trust, Leeds PubMed articles Google scholar articles
J Isaacs 5Institute of Cellular Medicine, Newcastle University and National Institute for Health Research Newcastle Biomedical Research Centre at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University, Newcastle PubMed articles Google scholar articles
AG Wilson 6UCD School of Medicine and Medical Science, Conway Institute, University College Dublin, Dublin, United Kingdom PubMed articles Google scholar articles
A Barton PubMed articles Google scholar articles

Citation

Oliver J, Plant D, Orozco G, et al

THU0002 Etanercept and adalimumab exhibit heterogeneous early signatures of response in rheumatoid arthritis therapy

Annals of the Rheumatic Diseases 2017;76:200.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password